Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-04-02Clinical Trial Update: Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer [NA]
Clinical trial evaluating Aprepitant and Ondansetron for opioid-induced nausea and vomiting in cancer patients; the study was withdrawn.
-
FDA approval · 2013-03-29FDA Approved: ZOLEDRONIC ACID — Original Application (Dr.Reddy's Laboratories Ltd)
FDA approved the original application for Zoledronic acid (generic) from Dr. Reddy's Laboratories Ltd. This approval confirms a generic vers…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer [Phase 2]
A phase 2 clinical trial evaluating a biological therapy after chemotherapy and peripheral stem cell transplantation in patients with variou…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer [Phase 1, Phase 2]
This Phase 1/2 trial evaluates a combination chemotherapy regimen followed by peripheral stem cell transplantation in patients with refracto…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease [NA]
This completed clinical trial examines donor stem cell transplantation after conditioning therapy in patients with hematologic cancers, recu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Sorafenib and Bortezomib in Treating Patients With Advanced Cancer [Phase 1]
A Phase 1 study to evaluate the combination of sorafenib and bortezomib in patients with advanced cancers, including refractory chronic lymp…
-
CLINICAL_TRIALS trial_result · 2013-03-18Clinical Trial Update: Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma [Phase 1]
The update covers a Phase 1 study of ACE-041 in patients with advanced solid tumors and relapsed/refractory multiple myeloma. The trial stat…
-
CLINICAL_TRIALS trial_result · 2013-03-18Clinical Trial Update: Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating SyB L-0501 for multiple myeloma was terminated. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma [Phase 2]
This update reports the completion of a Phase 2 study of canfosfamide in refractory or relapsed mantle cell lymphoma, B-cell lymphoma, and m…
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: A Study of a Human Anti-Intercellular Adhesion Molecule-1 Monoclonal Antibody, in Patients With Multiple Myeloma [Phase 1]
Phase 1 clinical trial evaluating a human anti-ICAM-1 monoclonal antibody in multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan
This clinical trial update indicates the study NCT00602147, investigating genetic mutations related to mucositis in multiple myeloma patient…
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: A Retreatment Study With Bortezomib for Multiple Myeloma
This clinical trial update reports a retreatment study of bortezomib for multiple myeloma, which has now been completed.
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma [Phase 2]
This Phase 2 trial evaluated thalidomide, doxorubicin, and dexamethasone in patients with untreated stage II or stage III multiple myeloma, …
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Sunitinib in Treating Patients With Relapsed Multiple Myeloma [Phase 2]
This is a Phase 2 trial of sunitinib in relapsed multiple myeloma (Stage I–III). The study has completed and results were posted in March 20…
-
FDA approval · 2013-03-04FDA Approved: ZOLEDRONIC ACID — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's zoledronic acid under an original application, enabling a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: CP-751,871 Treatment For Patients With Multiple Myeloma [Phase 1]
A Phase 1 trial of CP-751,871 in patients with multiple myeloma has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 trial of AE-941 for relapsed or refractory Multiple Myeloma has been completed, reported by AEterna Zentaris.
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma Patients [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/2 study evaluating the combination of sorafenib and bortezomib in relapsed or refr…
-
FDA approval · 2013-02-26FDA Approved: MOZOBIL — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Mozobil (plerixafor) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine [EARLY_Phase 1]
This clinical trial update reports completion of an early-phase 1 study evaluating cyclophosphamide and pulse dexamethasone with either rapa…
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Dinaciclib in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
This document reports the completion and posting of results for a Phase 2 clinical trial evaluating dinaciclib in patients with relapsed or …
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Bortezomib (Velcade) - Regulatory Post Marketing Surveillance (PMS)
A regulatory post-marketing surveillance study of bortezomib (Velcade) in Korea has completed. The study focused on patients with multiple m…
-
CLINICAL_TRIALS withdrawal · 2013-02-20Clinical Trial Update: Dovitinib Combined With Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma [Phase 1]
The phase 1 trial of dovitinib in combination with bortezomib and dexamethasone for relapsed/refractory multiple myeloma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-02-18Clinical Trial Update: A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients [Phase 1]
Phase 1 study evaluating BHQ880 in combination with zoledronic acid in relapsed or refractory multiple myeloma with bone disease has complet…
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma [Phase 1]
Phase 1 trial evaluating stem cell mobilization with plerixafor and filgrastim after cyclophosphamide in patients with multiple myeloma has …